Physician profile
Keith Blankenship
NPI 1467032110
$1,890.28
in general payments reported to CMS, 2019-2025
12 companies · $517 in 2025
The $517 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $278 · 2023: $310 · 2024: $425 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.40 |
| Education | $305.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $349.04 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $305.00 | 2025 | |
| Davol INC. | $248.97 | 2021-2024 | Phasix Mesh |
| Avanos Medical | $244.21 | 2021-2022 | |
| Solventum Corporation | $197.63 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Intuitive Surgical, INC. | $123.17 | 2021-2024 | |
| Abbvie INC. | $104.19 | 2021-2022 | |
| Ethicon US, LLC | $84.45 | 2024-2025 | Echelon Flex, Echelon Endopath, Contour |
| Sanara Medtech INC. | $84.33 | 2023-2025 | Celleraterx, Celleraterx |
| Kci USA, INC. | $75.54 | 2021 | |
| Smith+Nephew, INC. | $58.14 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.61 | 2024 | Avenir, Arcos, Persona |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.